MIRA
INFORM REPORT
|
Report Date : |
01.09.2014 |
IDENTIFICATION DETAILS
|
Name : |
WATSON PHARMA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
21-22, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.12.2013 |
|
|
|
|
Date of
Incorporation : |
21.10.2005 |
|
|
|
|
Com. Reg. No.: |
11-156968 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs. 550.025 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230MH2005PTC156968 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMW02844C |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACW6074D |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturing of pharmaceuticals. |
|
|
|
|
No. of Employees
: |
Not Divulged |
RATING & COMMENTS
|
MIRA’s Rating : |
A (57) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 22000000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having fine track record. Fundamentals of the company is decent. Financial position of the
company is strong and healthy. There are no external borrowing recorded by
the company. Trade relation reported to be fair. Business is active. Payment terms
are reported to be regular and as per commitment. The company can be considered
normal for business dealing at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
N E W S
As per the latest IMF study, the total weigh of emerging markets in the
GDP of the world on a purchasing power parity basis has seen a sizeable shift.
It highlights how as against 51 % in 2005, the emerging economies now account
for close to 56 % of the global purchasing power GDP as per the latest survey.
And with the emerging economies growing at a faster rate than their developed
counterparts, there are every possibility that the their share goes up further
in the coming years. China may surpass the US over the next few years.
Politics and economics are very intricately connected. They tend to
influence each other in ways that could be very complex and far-reaching. The
prospects of the India’s economy have been seriously compromised due to
political corruption. High inflation, poor standard of living are to a great
extent a result of rampant corruption in the country. China on the other hand,
seems to be facing diametrically opposite challenge. American hedge fund
manager Jim Chanos has been keenly following the political and economic
development in the dragon economy and has figured out something that is quite
worrying. He is of the view that the Chinese economy could be heading toward
trouble on account of new Chinese President Xi Jingping’s very aggressive
anti-corruption drive. Chanos believes tat many things such as apartment sales,
luxury products, etc. were largely bought with dirty money. And it is now
beginning to impact consumption. This may indeed be bad news for an economy
that is struggling to transition from an investment-driven export-oriented
economy to a domestic consumption-driven economy.
A study published by Firstpost has revealed that asset classes like real
estate and equities were the biggest beneficiaries of the liberalization
policies. A firm called Ciane Analytics studied returns from assets
including equities, gold, fixed deposits, G-Secs and real estate since 1991.
Real estate outperformed every other asset classes during the 23-year period
with an annualized return of 20 % ! Equities came in second with annualized
return of 15.5 % ! However, while these returns may seem mouthwatering, the
fact is that the return from equities adjusted for inflation came down to just
7.1 %.
Some brief news are as under
. R-Power to buy Jaypee’s hydro assets
. Investors await justice in NSEL case
. India seeks MFN status from Pakistan ahead of meeting
. Ukrain’s clashes with rebels hinder MH17 crash investigation
. India exploring merger of state-owned hydro PSUs
..Higher costs weigh down profit growth to slowest in 9 quarters
..Wal-Mart to expand wholesale business in India
. GMR group moves to strengthen balance sheet
. Central Bank to sell 4 % stake to Life Insurance Corporation
. Tata Chemicals plans to raise up to Rs 10000 mn.
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION DENIED BY
|
Name : |
Mr. Anand Kalani |
|
Designation : |
Accounts Manager |
|
Contact No.: |
91-22-66886700 |
|
Date : |
28.08.2014 |
LOCATIONS
|
Registered Office : |
21-22, Kalpataru Square, Kondivita Off Andheri Kurla Road, Andheri
(East), Mumbai – 400059, Maharashtra, India
|
|
Tel. No.: |
91-22-66886700 |
|
Fax No.: |
91-22-66886799 |
|
E-Mail : |
rajesh.sharma@watsonpharm.co.in muralidharan.cs@watsonpharma.co.in
shivshanker.shenoy@watsonpharm.co.in
|
|
Website : |
|
|
|
|
|
Regional Office : |
201/301, Corporate Enclave, B. D. Sawant Marg, Chakala, Andheri
(East), Mumbai – 400099, Maharashtra, India |
DIRECTORS
As on 29.05.2014
|
Name : |
Mr. David Adam Irving Buchen |
|
Designation : |
Director |
|
Address : |
1967, |
|
Date of Birth/Age : |
22.06.1964 |
|
Date of Appointment : |
21.10.2005 |
|
DIN No.: |
00839184 |
|
|
|
|
Name : |
Patrick Gerard Brunner |
|
Designation : |
Director |
|
Address : |
10231, |
|
Date of Birth/Age : |
13.06.1963 |
|
Date of Appointment : |
20.05.2010 |
|
DIN No.: |
03024470 |
|
|
|
|
Name : |
Mr. Muralidharan Sundaresan Chinnadharavaram |
|
Designation : |
Managing Director |
|
Address : |
302 B Wing, |
|
Date of Birth/Age : |
05.02.1963 |
|
Date of Appointment : |
20.05.2010 |
|
DIN No.: |
|
|
|
|
|
Name : |
Mr. Krishnaprasad Chandrasekara Hassan |
|
Designation : |
Director |
|
Address : |
A 502, Dream Heights, Plot No. 28, Kharghar, Sector – 19, Navi Mumbai – 410210, Maharashtra, India |
|
Date of Birth/Age : |
29.08.1966 |
|
Date of Appointment : |
30.09.2013 |
|
DIN No.: |
06719389 |
|
|
|
|
Name : |
Mr. Jayant Shyam Sunder Bapna |
|
Designation : |
Director |
|
Address : |
|
|
Date of Birth/Age : |
17.07.1958 |
|
Date of Appointment : |
23.05.2011 |
|
DIN No.: |
03511093 |
|
|
|
|
Name : |
Mr. Robert Allan Stewart |
|
Designation : |
Director |
|
Address : |
Heritage Village VIII, 4 Quail Run BLK 47.02 LT 1.02 |
|
Date of Birth/Age : |
03.05.1967 |
|
Date of Appointment : |
23.05.2011 |
|
DIN No.: |
03515778 |
|
|
|
|
Name : |
Mr. Philip Abraham Biju |
|
Designation : |
Director |
|
Address : |
|
|
Date of Birth/Age : |
04.11.1969 |
|
Date of Appointment : |
23.05.2011 |
|
DIN No.: |
03515838 |
KEY EXECUTIVES
|
Name : |
Mr. Anand Kalani |
|
Designation : |
Accounts Manager |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 29.05.2014
|
Names of Shareholders |
|
No. of Shares |
|
Watson Laboratories Inc, USA |
|
55002460 |
|
Watson Pharma Inc, Parsippany |
|
1 |
|
Total |
|
55002461 |
Equity Share Break up (Percentage of Total Equity)
As on 29.05.2014
|
Category |
Percentage |
|
Foreign holdings( Foreign institutional
investor(s), Foreign companie(s) Foreign financial institution(s),
Non-resident Indian(s) or Overseas Corporate bodies or Others |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing of pharmaceuticals. |
||||||||||||
|
|
|
||||||||||||
|
Products : |
|
PRODUCTION STATUS (AS ON : 31.12.2011)
|
Particulars |
Unit |
Installed
Capacity |
Actual
Production |
|
Drugs and Pharmaceuticals |
|
|
|
|
Active Pharmaceutical Ingredients |
Tones |
112 |
86 |
|
Formulations – Tablets and Capsules |
Million Nos. |
3000 |
2855 |
*Licensed Capacity
is not applicable as industrial licensing has been abolished in respect of these
products vide Notification No. SO-477(E) dated 25th July, 1991 as amended vide
Press Release Note No. 4 of the 1994 series dated 25th October, 1994 issued by
the Department of Industrial Development, Ministry of Industry, Government of
India
'@Installed
Capacity (Active Pharmaceutical Ingredients at Ambernath plant on triple shift
basis, Formulations at Goa plant on triple shift basis and Formulations at
Ambernath plant on single shift basis) being a technical matter, is certified
by the management and relied upon by the auditors.
GENERAL INFORMATION
|
No. of Employees : |
Not Divulged |
|
|
|
|
Bankers : |
· HDFC Bank Limited, HDFC Bank Housesenapati Bapat Marg, Lower Parel W, Mumbai - 400013, Maharashtra, India · Standard Chartered Bank, Mumbai Branch, 90 Mg Road, Mumbai - 400001, Maharashtra, India |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Lovelock and Lewes Chartered Accountants |
|
Address : |
252, Veer Savarkar Marg, Shivaji Park, Dadar, Mumbai – 400 028,
Maharashtra, India |
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AABFL5878L |
|
|
|
|
Ultimate Holding Company : |
· Actavis, Inc., USA (formerly Watson Pharmaceuticals, Inc.) (up to 30th September, 2013) ·
Actavis plc., Ireland (from 1st October, 2013) |
|
|
|
|
Holding Company : |
·
Watson Laboratories, Inc., USA |
|
|
|
|
Fellow Subsidiaries : |
· Actavis, Inc., USA (from 1st October, 2013) · Actavis Farmaceutica Ltda, Brazil (formerly Arrow Farmaceutica Ltda) · Arrow No. 7 Limited, UK · Arrow Pharma (Malta) Limited, Malta · Cobalt Pharmaceuticals Inc., Canada · Specifar Pharmaceuticals, Greece · Watson Pharma (PTY) Limited., South Africa · Spirit Pharmaceuticals Pty Limited., Australia · Actavis Mid-Atlantic LLC, USA · Actavis Group PTC Ehf, Iceland · Actavis Pharma Manufacturing Private Limited, India (up to 31st July, 2013) · Lotus Labs Private Limited, India · Watson Pharma Inc., USA · Actavis KK, Japan ·
Actavis PTY Limited, Australia |
CAPITAL STRUCTURE
As on 31.12.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
75000000 |
Equity Shares |
Rs.10/- each |
Rs. 750.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
55002461 |
Equity Shares |
Rs.10/- each |
Rs. 550.025
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES
OF FUNDS |
31.12.2013 |
31.12.2012 |
31.12.2011 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
550.025 |
550.025 |
550.025 |
|
(b) Reserves & Surplus |
5171.215 |
4614.921 |
3939.668 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
5721.240 |
5164.946 |
4489.693 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
545.193 |
|
(b) Deferred tax liabilities
(Net) |
243.247 |
258.658 |
196.111 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term provisions |
61.815 |
25.677 |
14.029 |
|
Total
Non-current Liabilities (3) |
305.062 |
284.335 |
755.333 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Trade payables |
852.634 |
732.988 |
735.698 |
|
(c) Other current liabilities |
260.276 |
766.065 |
794.008 |
|
(d) Short-term provisions |
18.374 |
32.448 |
9.686 |
|
Total
Current Liabilities (4) |
1131.284 |
1531.501 |
1539.392 |
|
|
|
|
|
|
TOTAL |
7157.586 |
6980.782 |
6784.418 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
3234.258 |
3268.962 |
2764.305 |
|
(ii) Intangible Assets |
66.312 |
66.440 |
46.988 |
|
(iii) Capital work-in-progress |
642.426 |
223.350 |
482.876 |
|
(iv) Intangible assets under
development |
0.083 |
19.309 |
3.879 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
589.373 |
478.578 |
510.212 |
|
(e) Other Non-current assets |
1.618 |
1.439 |
1.333 |
|
Total
Non-Current Assets |
4534.070 |
4058.078 |
3809.593 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
226.795 |
50.238 |
|
(b) Inventories |
2121.343 |
2084.216 |
1766.609 |
|
(c) Trade receivables |
322.364 |
394.044 |
296.462 |
|
(d) Cash and cash equivalents |
113.834 |
107.836 |
590.382 |
|
(e) Short-term loans and
advances |
65.537 |
109.263 |
267.000 |
|
(f) Other current assets |
0.438 |
0.550 |
4.134 |
|
Total
Current Assets |
2623.516 |
2922.704 |
2974.825 |
|
|
|
|
|
|
TOTAL |
7157.586 |
6980.782 |
6784.418 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.12.2013 |
31.12.2012 |
31.12.2011 |
|
|
SALES |
|
|
|
|
|
Revenue |
7295.821 |
6990.709 |
5453.653 |
|
|
Other Income |
NA |
NA |
NA |
|
|
TOTAL
|
NA |
NA |
NA |
|
|
|
|
|
|
|
Less |
EXPENSES |
NA |
NA |
NA |
|
|
|
|
|
|
|
Less |
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
1273.196 |
1376.525 |
966.813 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
3.343 |
11.996 |
11.924 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
1269.853 |
1364.529 |
954.889 |
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION |
409.922 |
360.755 |
322.128 |
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAXATION AND PRIOR PERIOD ITEMS |
859.931 |
1003.774 |
632.761 |
|
|
|
|
|
|
|
Less |
Prior
Period Items |
0.000 |
7.316 |
30.616 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
859.931 |
996.458 |
602.145 |
|
|
|
|
|
|
|
Less |
TAX |
303.637 |
321.205 |
158.671 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
556.294 |
675.253 |
443.474 |
|
|
|
|
|
|
|
|
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
2806.930 |
2131.677 |
1688.202 |
|
|
|
|
|
|
|
|
Balance
Carried to the B/S |
3363.224 |
2806.930 |
2131.677 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (Rs.) |
10.11 |
12.28 |
8.06 |
KEY RATIOS
|
PARTICULARS |
|
31.12.2013 |
31.12.2012 |
31.12.2011 |
|
PAT / Total Income |
(%) |
7.62 |
9.66 |
8.13 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
11.79 |
14.25 |
11.04 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
13.20 |
14.79 |
9.56 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.15 |
0.19 |
0.13 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.00 |
0.00 |
0.12 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.32 |
1.91 |
1.93 |
FINANCIAL ANALYSIS
[all figures are in
Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.12.2011 |
31.12.2012 |
31.12.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Share Capital |
550.025 |
550.025 |
550.025 |
|
Reserves & Surplus |
3939.668 |
4614.921 |
5171.215 |
|
Net
worth |
4489.693 |
5164.946 |
5721.240 |
|
|
|
|
|
|
long-term borrowings |
545.193 |
0.000 |
0.000 |
|
Short term borrowings |
0.000 |
0.000 |
0.000 |
|
Total
borrowings |
545.193 |
0.000 |
0.000 |
|
Debt/Equity
ratio |
0.121 |
0.000 |
0.000 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.12.2011 |
31.12.2012 |
31.12.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Revenue |
5453.653 |
6990.709 |
7295.821 |
|
|
|
28.184 |
4.365 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.12.2011 |
31.12.2012 |
31.12.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Revenue |
5453.653 |
6990.709 |
7295.821 |
|
Profit |
443.474 |
675.253 |
556.294 |
|
|
8.13% |
9.66% |
7.62% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director,
if available |
No |
|
34] |
External Agency Rating,
if available |
No |
INDEX OF CHARGES
|
S.NO. |
CHARGE ID |
DATE OF CHARGE
CREATION/MODIFICATION |
CHARGE AMOUNT
SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST
NUMBER (SRN) |
|
1 |
10163588 |
23/06/2009 |
250,000,000.00 |
HDFC BANK LIMITED |
HDFC BANK HOUSESENAPATI BAPAT MARG, LOWER PAREL W, MUMBAI, MAHARASHTRA - 400013, INDIA |
A64359128 |
FIXED ASSETS
Intangible Assets:
·
Technical know-how
·
Computer Software
·
Others
Tangible Assets:
·
Leasehold Land
·
Buildings
·
Plant and Machinery
·
Office Equipments
·
Computers
·
Laboratory Equipment
·
Furniture and Fittings
·
Vehicles
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.47 |
|
|
1 |
Rs.100.35 |
|
Euro |
1 |
Rs.79.86 |
INFORMATION DETAILS
|
Information
Gathered by : |
HTL |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
KVT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
|
|
|
|
TOTAL |
|
57 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.